Pharmaceutical Pricing and Reimbursement in Spain, 2008Decision Resources
August 28, 2008
34 Pages - SKU: DECR1904353
More Pricing reports by Decision Resources
Turkey: Market Access Tracker by Decision Resources
The Turkish pharmaceutical market is the 6th largest in Europe and the 16th largest in the world and experienced rapid growth until 2011. A ...
Italy: Market Access Tracker by Decision Resources
The Italian pharmaceutical market is the third largest in Europe and the eighth largest in the world, with ex-manufacturer sales in retail pharmacies ...
Europe: Market Access Tracker by Decision Resources
Decision Resources’ Market Access Tracker service for Europe explains the challenges and opportunities to gaining and maintaining favorable market access terms in the mature and ...
China: Market Access Tracker by Decision ResourcesSee all reports like this >>
Decision Resources’ Market Access Tracker service for the Asia Pacific region explains the challenges and opportunities to gaining and maintaining favorable market access terms in ...
More Spain Pricing reports
Spain: Market Access Tracker by Decision Resources
Although Spain has a much smaller population than the United Kingdom, the Spanish pharmaceutical market has recently overtaken the U.K. market as the ...
The Pharmaceutical Market: Spain by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
5EU: Pricing, Reimbursement and Regulatory Update by Datamonitor
IntroductionGovernments across the five major EU markets (France, Germany, Italy, Spain, and the UK) have been busy implementing regulatory, pricing, and reimbursement reforms in 2011. ...
Spain Pharmaceutical Market Overview - Price cuts set to negatively impact both branded and generics companies by DatamonitorSee all reports like this >>
IntroductionThe Spanish prescription pharmaceutical market was valued at $22.1bn in sales in 2009, with an annual growth rate of 6.4% between 2008 and 2009. Key ...
More Spain reports
D&B Country RiskLine Report: Spain by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: Spain by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Spain: Country Profile by MarketLine
INTRODUCTIONThis report provides a detailed analysis of Spain, providing an overview of its political, economic and business environment, represented both textually and in graph and ...
2007 Spain Industry & Market Outlook report by Barnes ReportsSee all reports like this >>
The 2007 Spain Industry & Market Outlook report is the leading annual publication that describes over 100 major industries in Spain and 500+ minor industries ...
We can help you find what you need. Call us or write us:
Need help in your search?
- Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational Players
- Healthcare, Regulatory and Reimbursement Landscape - Finland
- Healthcare, Regulatory and Reimbursement Landscape - Austria
- Risk Sharing and Other Forms of Managed Entry Agreements for Medicines, Worldwide
- Acquired Orphan Blood Diseases Therapeutics Market to 2019 - Search for Disease Modifying Drugs Central to Unlocking Premium Pricing Potential